TALIGEN THERAPEUTICS

Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company's lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen's founders have validated as an important amplification loop in the inflammation process.

#People #Financial #Event #Website #More

TALIGEN THERAPEUTICS

Industry:

Biotechnology Health Care Medical

Founded:

2004-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.taligentherapeutics.com

Total Employee:

11+

Status:

Closed

Contact:

617-444-8443

Email Addresses:

[email protected]

Total Funding:

78.75 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Font Awesome Mobile Non Scaleable Content LiteSpeed Hetzner

Current Employees Featured

woodruff-emlen_image

Woodruff Emlen
Woodruff Emlen President and co-founder @ Taligen Therapeutics
President and co-founder

Founder

woodruff-emlen_image

Woodruff Emlen

Investors List

alta-partners_image

Key Employee Changes

Date	New article
2024-09-26	Qualigen Therapeutics appoints Kevin Richardson as Interim CEO and CFO

Official Site Inspections

http://www.taligentherapeutics.com

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...